# Clinical trials recruiting in China: 15,793 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 15,793 trials recruiting or not yet recruiting with a site in China, as read on November 19, 2026.

## The full list

Clinical trials recruiting in China: 15,793 rows for $237.93, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 462 rows a month: $23.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/china

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 15,793
- Recruiting or not yet: 15,793
- Read on: November 19, 2026

## Trials

The 25 newest of 15,793, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947043 | Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection | Tongji Hospital | Phase 1 | Recruiting | Recurrent or Metastatic Lung Cancer or Cervical Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947043) |
| November 18, 2026 | NCT07946913 | A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic... | Longbio Pharma | Phase 3 | Not yet recruiting | Chronic Spontaneous Urticaria (CSU) | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946913) |
| November 18, 2026 | NCT07946757 | Phase Ib Clinical Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic Hepatitis B | Xiamen Amoytop Biotech Co., Ltd. | Phase 1 | Not yet recruiting | Chronic Hepaititis B | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946757) |
| November 18, 2026 | NCT07946744 | Physical Frailty Intervention for Older Adults With Hypertension and Physical Frailty | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Frailty, Hypertension (HTN) | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946744) |
| November 18, 2026 | NCT07946549 | A Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia | CASI pharmaceuticals, Inc. | Phase 2 | Not yet recruiting | Chronic Immune Thrombocytopenia | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946549) |
| November 18, 2026 | NCT07946146 | A Single-Center, Prospective Clinical Cohort Study on Perioperative Management, Exposure, Multiorgan Outcomes, and Functional Recovery in... | Beijing Tsinghua Chang Gung Hospital | Observational | Recruiting | Liver Transplantation (LT), Perioperative Care, Prospective Studies, Cohort Studies, Postoperative Complications... | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946146) |
| November 18, 2026 | NCT07946094 | Evaluation of the Effect of Comprehensive Myopia Control Interventions on Myopia Prevention and Control | Beijing Tongren Hospital | Not applicable | Recruiting | Myopia, Childhood Myopia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946094) |
| November 18, 2026 | NCT07946042 | Safety, Tolerability, and Pharmacokinetic Study of Single and Multiple Ascending Dose of YY524051 Tablets in Healthy Adults. | Beijing Baheal Wisart Medical Research Co., Ltd | Phase 1 | Not yet recruiting | Healthy Adult | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946042) |
| November 18, 2026 | NCT07945795 | RDN for CKD and Uncontrolled Hypertension Trial | Beijing Anzhen Hospital | Not applicable | Recruiting | Hypertension, CKD - Chronic Kidney Disease | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945795) |
| November 18, 2026 | NCT07945756 | Development of a Gastric Cancer Screening Intervention for H. Pylori Carriers Based on the Health Belief Model | Chinese University of Hong Kong | Not applicable | Not yet recruiting | Gastric Cancer (GC) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945756) |
| November 18, 2026 | NCT07945743 | Muscle Synergy-Inspired Functional Electrical Stimulation for Rehabilitating Hand Motor Functions Post-Stroke | Chinese University of Hong Kong | Not applicable | Recruiting | Stroke | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945743) |
| November 18, 2026 | NCT07945665 | Diagnostic Performance and Safety of Ragweed Pollen and Dog Dander Skin Prick Test Solutions | Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Allergic Disorder | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945665) |
| November 18, 2026 | NCT07945613 | IoC2-Guided Remifentanil Titration for Early Postoperative Pain After Laparoscopic Cholecystectomy | Sponsor not shown (see the record) | Not applicable | Recruiting | Pain | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945613) |
| November 18, 2026 | NCT07945353 | Orelabrutinib Plus 4 Gy Radiotherapy Versus 24 Gy Radiotherapy for Stage I/II MALT Lymphoma | Fudan University | Phase 2 | Not yet recruiting | MALT Lymphoma | 272 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945353) |
| November 18, 2026 | NCT07945314 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3839056 in Healthy Participants | Eli Lilly and Company | Phase 1 | Not yet recruiting | Healthy Participants | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945314) |
| November 18, 2026 | NCT07945275 | A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of... | Shandong University | Phase 2 | Recruiting | PD Target Attainment Rate, Pneumonia, Elderly (People Aged 65 or More) | 118 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945275) |
| November 18, 2026 | NCT07945158 | MRS Imaging Evaluation for Acute Minor Stroke | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Observational | Recruiting | Acute Ischemic Stroke | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945158) |
| November 18, 2026 | NCT07945145 | A Pharmacokinetics Study of GZR33 Injection at Different Injection Sites | Gan & Lee Pharmaceuticals. | Phase 1 | Not yet recruiting | Healthy Participants | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945145) |
| November 18, 2026 | NCT07945132 | An Observational Study of the Medical-Grade Wireless Wearable Data for Predicting Hypoxemia Risk and Evaluating Workflow Efficiency in... | Sponsor not shown (see the record) | Observational | Not yet recruiting | Hypoxemia | 772 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945132) |
| November 18, 2026 | NCT07945119 | Safety, Tolerability, and Efficacy of a Therapeutic Intervention for HPV16/18 Infection | Beijing Xunsheng Biomedical Research Co., Ltd. | Not applicable | Recruiting | Positive for HPV16/18 Infection | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945119) |
| November 18, 2026 | NCT07944846 | A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Nasal Spray for... | Tongji Hospital | Observational | Recruiting | Preoperative Anxiety in Children | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944846) |
| November 18, 2026 | NCT07944833 | Mechanical Characterization of Vestibular Schwannoma: Classification Based on Magnetic Resonance Elastography and Its Clinical Relevance... | Shengjing Hospital | Observational | Recruiting | Vestibular Schwannoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944833) |
| November 18, 2026 | NCT07944716 | Function-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI | Shanghai Zhongshan Hospital | Not applicable | Not yet recruiting | Coronary Disease | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944716) |
| November 18, 2026 | NCT07944690 | A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX49 in Advanced/Metastatic Solid Tumors | Shanghai Henlius Biotech | Phase 1 | Not yet recruiting | Advanced/Metastatic Solid Tumors | 222 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944690) |
| November 18, 2026 | NCT07944651 | Pirtobrutinib With Sonrotoclax and Rituximab for High-Risk Relapsed/Refractory Mantle-Cell Lymphoma Following Covalent BTK-Inhibitor Failure | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Not yet recruiting | Mantle Cell Lymphoma (MCL), Relapsed/Refractory Mantle Cell Lymphoma (MCL) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944651) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Fudan University Shanghai Cancer Center | Shanghai | 533 |
| Sun Yat-sen University Cancer Center | Guangzhou | 455 |
| Peking Union Medical College Hospital | Beijing | 388 |
| Henan Cancer Hospital | Zhengzhou | 321 |
| Zhejiang Cancer Hospital | Hangzhou | 317 |
| Beijing Cancer Hospital | Beijing | 311 |
| Peking University People's Hospital | Beijingcun | 301 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | 299 |
| Peking University First Hospital | Beijing | 293 |
| Peking University Third Hospital | Beijing | 281 |
| Hunan Cancer Hospital | Changsha | 278 |
| Qilu Hospital of Shandong University | Jinan | 249 |
| Guangdong Provincial People's Hospital | Guangzhou | 236 |
| The First Affiliated Hospital of Nanchang University | Nanchang | 236 |
| West China Hospital of Sichuan University | Chengdu | 232 |
| West China Hospital, Sichuan University | Chengdu | 226 |
| Harbin Medical University Cancer Hospital | Harbin | 224 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | 219 |
| Fujian Cancer Hospital | Fuzhou | 210 |
| The First Hospital of Jilin University | Changchun | 199 |
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | 179 |
| Shanghai Chest Hospital | Shanghai | 178 |
| The First Affiliated Hospital of Soochow University | Suzhou | 178 |
| Fujian Medical University Union Hospital | Fuzhou | 169 |
| Jiangsu Province Hospital | Nanjing | 163 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 496 |
| Phase 1 | 1,468 |
| Phase 1/2 | 1,083 |
| Phase 2 | 3,068 |
| Phase 2/3 | 243 |
| Phase 3 | 1,526 |
| Phase 4 | 583 |
| Not applicable | 4,028 |
| Observational | 3,298 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 557 |
| Breast Neoplasms | 549 |
| Colorectal Neoplasms | 333 |
| Stomach Neoplasms | 322 |
| Carcinoma, Hepatocellular | 303 |
| Ischemic Stroke | 294 |
| Lung Neoplasms | 274 |
| Recurrence | 258 |
| Neoplasms | 252 |
| Pancreatic Neoplasms | 215 |
| Leukemia, Myeloid, Acute | 192 |
| Multiple Myeloma | 186 |
| Obesity | 184 |
| Prostatic Neoplasms | 166 |
| Stroke | 163 |
| Diabetes Mellitus, Type 2 | 155 |
| Esophageal Neoplasms | 153 |
| Nasopharyngeal Carcinoma | 147 |
| Ovarian Neoplasms | 141 |
| Lupus Erythematosus, Systemic | 135 |
| Coronary Artery Disease | 134 |
| Small Cell Lung Carcinoma | 134 |
| Neoplasm Metastasis | 133 |
| Uterine Cervical Neoplasms | 127 |
| Rectal Neoplasms | 126 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fudan University | 423 |
| Sun Yat-sen University | 401 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 351 |
| Ruijin Hospital | 249 |
| Peking Union Medical College Hospital | 234 |
| Beijing Tiantan Hospital | 206 |
| Institute of Hematology & Blood Diseases Hospital, China | 187 |
| The First Affiliated Hospital with Nanjing Medical University | 183 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 177 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 171 |
| Shanghai Zhongshan Hospital | 159 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 159 |
| Xuanwu Hospital, Beijing | 158 |
| Tianjin Medical University Cancer Institute and Hospital | 153 |
| Peking University People's Hospital | 152 |
| West China Hospital | 148 |
| Peking University Third Hospital | 142 |
| Chinese PLA General Hospital | 132 |
| Tongji Hospital | 128 |
| Peking University First Hospital | 126 |
| Nanfang Hospital, Southern Medical University | 123 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 122 |
| RenJi Hospital | 119 |
| Qilu Hospital of Shandong University | 103 |
| Xijing Hospital | 102 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B signage companies in the United States](https://specstream.ai/data/businesses/b2b-signage-companies/united-states)
- [Endodontics practices in the United States](https://specstream.ai/data/businesses/endodontics-practices/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Russian restaurants in the United States](https://specstream.ai/data/businesses/russian-restaurants/united-states)
- [Appliance repair companies in the United States](https://specstream.ai/data/businesses/appliance-repair-companies/united-states)
- [Demolition contractors in the United States](https://specstream.ai/data/businesses/demolition-contractors/united-states)
